Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results - Aix-Marseille Université Access content directly
Journal Articles Current Opinion in Oncology Year : 2020

Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results

Essia Mezni

Domains

Cancer
No file

Dates and versions

hal-03623648 , version 1 (29-03-2022)

Identifiers

Cite

Anthony Goncalves, Essia Mezni, F. Bertucci. Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results. Current Opinion in Oncology, 2020, 32 (6), pp.585-593. ⟨10.1097/cco.0000000000000680⟩. ⟨hal-03623648⟩

Collections

CNRS UNIV-AMU CRCM
7 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More